Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2000
10/12/2000WO2000017232A3 Regulatory protein from human keratinocytes
10/12/2000WO2000015790A9 Leptin induced genes
10/12/2000WO2000015238A9 COMPOSITIONS OF β-GLUCANS AND SPECIFIC IGIV
10/12/2000WO2000005250A9 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
10/12/2000WO1999064039A9 Bradykinin antagonists
10/12/2000WO1999051188A9 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/12/2000WO1999041376A8 Retinoblastoma protein complexes and retinoblastoma interacting proteins
10/12/2000WO1997036919A3 Cytokine designated lerk-8
10/12/2000DE10004815A1 Human sodium-phosphate cotransporter Npt2B, useful e.g. for identifying agents for treating hyper- and hypo-phosphatemia, and related nucleic acid
10/12/2000CA2368225A1 Antigen-specific induction of peripheral immune tolerance
10/12/2000CA2368017A1 Use of erbb receptor ligands in treating diabetes
10/12/2000CA2367412A1 Compositions and methods for the therapy and diagnosis of prostate cancer
10/12/2000CA2367403A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000CA2367390A1 Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367210A1 Bacterial fimbrial system for presentation of heterologous peptide sequences
10/12/2000CA2366895A1 Immunomodulating polymers
10/12/2000CA2366787A1 Compositions and methods for treating lymphoma
10/12/2000CA2365526A1 Recombinant influenza viruses for vaccines and gene therapy
10/12/2000CA2365221A1 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000CA2365040A1 Hob-bp2h compositions, methods and uses thereof
10/11/2000EP1043399A2 Hepatitis C Virus cell culture system
10/11/2000EP1043333A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
10/11/2000EP1042495A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria
10/11/2000EP1042492A1 Humanized monoclonal antibodies that protect against shiga toxin induced disease
10/11/2000EP1042480A1 Streptococcal heat shock proteins of the hsp60 family
10/11/2000EP1042476A1 Insulin-like growth factor binding protein fragments and the utilization thereof
10/11/2000EP1042456A1 Human nucleotide pyrophosphohydrolase-2
10/11/2000EP1042450A1 ISOLATED STRAINS OF $i(STAPHYLOCOCCUS AUREUS) AND VACCINES MANUFACTURED THEREFROM
10/11/2000EP1042368A1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
10/11/2000EP1042365A1 Compounds and methods for modulating occludin related tissue permeability
10/11/2000EP1042363A1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids
10/11/2000EP1042360A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/11/2000EP1042342A1 53 human secreted proteins
10/11/2000EP1042339A2 Carbohydrates, useful in solid delivery systems
10/11/2000EP1042001A1 Use of microparticles combined with submicron oil-in-water emulsions
10/11/2000EP1041994A1 Use of parasitic biological agents for prevention and control of autoimmune diseases
10/11/2000EP1041888A1 Anti-retroviral immunogens, preparation and use
10/11/2000EP0710121B1 Method for treating multiple sclerosis
10/11/2000EP0702689B1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids
10/11/2000CN1269832A Kay-novel immune system protein
10/11/2000CN1269804A CTL epitopes from EBV
10/11/2000CN1269728A Decreased fat absorption with anti-lipase antibody
10/11/2000CN1269722A Method and composition for modulating responsiveness to corticosteroids
10/11/2000CN1269245A Static hydraulic process to prepare influenza virus vaccine
10/11/2000CN1269244A Nanometer-level influenza virus splitting process to make subunit vaccine
10/11/2000CN1269243A Deactivated clostridium perfringens disease vaccine for ox and its preparation
10/10/2000US6130325 Human P24 vesicle proteins
10/10/2000US6130202 Antiviral methods
10/10/2000US6130091 Method for obtaining a peptide derived from the respiratory syncytial virus polypeptide and bacterium expressing it
10/10/2000US6130087 Methods for generating cytotoxic T cells in vitro
10/10/2000US6130085 Expression plasmid for the cloning, expression, and exposure of a heterologous polypeptide on the surface of the external membrane of a gram-negative bacteria; for production of antibodies against bacterial parasites
10/10/2000US6130082 Expression vector coding fusion protein capable of eliciting an immune response against infection by the heterologous microorganism
10/10/2000US6130071 Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
10/10/2000US6130069 Nucleotide sequences coding a synthetase; for the diagnosis and treatment of bacterial infections; for the detection of agonist and antagonist of bacterial infection; bactericides
10/10/2000US6130064 Amino acid sequence encoded by polynucleotide from survival motor neuron gene; diagnosis, treatment, and prevention of nervous system, reproductive, and cell proliferative disorders; antiproliferative/anticarcinogenic agents
10/10/2000US6130060 Gene encoding for adseverin
10/10/2000US6129923 Treatment of H. pylori associated gastroduodenal disease
10/10/2000US6129922 Methods for adjuvant free hepatitis A virus vaccination
10/10/2000US6129921 Viral ribonucleocapsid as an immunological enhancer
10/10/2000US6129920 Inactivated infectious bursal disease vaccine
10/10/2000US6129917 Immunogenic compositions comprising porphyromonas gingivalis proteins and/or peptides and methods
10/10/2000US6129914 Bispecific antibody effective to treat B-cell lymphoma and cell line
10/10/2000US6129913 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
10/10/2000CA2030516C Parathyroid hypertensive factor
10/10/2000CA2002839C Parvovirus capsids
10/10/2000CA1341115C Rhoptry membrane antigen of plasmodium falciparum
10/09/2000CA2303722A1 Campylobacter vaccine
10/08/2000CA2266760A1 Methylation of arginine and related amino acids
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058506A2 Susceptibility to psoriasis
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058475A2 Streptococcus pneumoniae antigens
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058468A2 47 human secreted proteins
10/05/2000WO2000058460A2 Casb619 involved in colon cancers
10/05/2000WO2000058456A2 Compositions and methods for modifying toxic effects of proteinacious compounds
10/05/2000WO2000058444A2 Adaptation of virus to vertebrate cells
10/05/2000WO2000058365A1 Specific binding proteins for treating canine allergy
10/05/2000WO2000058363A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
10/05/2000WO2000058358A1 49 human secreted proteins
10/05/2000WO2000058356A1 50 human secreted proteins
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058349A1 Peptide vaccine for canine allergy
10/05/2000WO2000058344A1 Proteins modified by xanthurenic acid
10/05/2000WO2000058341A1 Hookworm platelet inhibitor
10/05/2000WO2000057919A2 Lipid-based artificial particles inducing cell-mediated immunity
10/05/2000WO2000057917A2 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
10/05/2000WO2000057912A1 Novel porcine protein and uses thereof
10/05/2000WO2000057911A2 Hapten-conjugated mammalian cells and methods of making and using thereof
10/05/2000WO2000057910A1 Attenuated dengue-4 virus vaccine
10/05/2000WO2000057909A2 Attenuated dengue-2 virus vaccine
10/05/2000WO2000057908A2 Attenuated dengue-1 virus vaccine
10/05/2000WO2000057907A2 Multivalent dengue virus vaccine
10/05/2000WO2000057906A1 Human papillomavirus vaccine with disassembled and reassembled virus-like particles
10/05/2000WO2000057905A1 Recombinant neospora antigens and their uses
10/05/2000WO2000057904A2 Attenuated dengue-3 virus vaccine
10/05/2000WO2000057901A1 Modulation of vascular permeability by means of tie2 receptor activators
1 ... 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 ... 1823